Market Currents
J&J (JNJ) won't enforce its patents on its HIV/AIDS drug Prezista in sub-Saharan Africa and...
-
Thursday, November 29, 2012, 9:38 AM ETJ&J (JNJ) won't enforce its patents on its HIV/AIDS drug Prezista in sub-Saharan Africa and other poor countries, allowing generic pharmaceutical companies to manufacture cheap versions of the drug as long as the quality remains high. However, J&J won't share its IP in the new Medicines Patent Pool, saying it wants "to reserve the right to reinforce patents."
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
